Nu Skin Enterprises (NYSE:NUS – Get Free Report) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.190-0.290 for the period, compared to the consensus estimate of 0.200. The company issued revenue guidance of $410.0 million-$445.0 million, compared to the consensus revenue estimate of $441.0 million. Nu Skin Enterprises also updated its FY 2024 guidance to 0.650-0.750 EPS.
Nu Skin Enterprises Stock Performance
NUS traded up $0.10 during trading hours on Friday, reaching $6.55. The company’s stock had a trading volume of 991,684 shares, compared to its average volume of 751,884. Nu Skin Enterprises has a 52 week low of $5.95 and a 52 week high of $20.75. The company’s 50-day moving average is $6.85 and its 200-day moving average is $9.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.12. The firm has a market cap of $325.54 million, a PE ratio of -2.20 and a beta of 1.14.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The firm had revenue of $439.10 million during the quarter, compared to the consensus estimate of $431.87 million. During the same period last year, the company earned $0.54 earnings per share. The business’s quarterly revenue was down 12.2% on a year-over-year basis. On average, equities analysts forecast that Nu Skin Enterprises will post 0.78 EPS for the current year.
Nu Skin Enterprises Announces Dividend
Wall Street Analyst Weigh In
A number of research firms have commented on NUS. Citigroup lowered their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd. DA Davidson reduced their price objective on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a research report on Monday, August 12th. Finally, StockNews.com downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Wednesday, October 23rd.
Check Out Our Latest Report on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Stories
- Five stocks we like better than Nu Skin Enterprises
- Investing in the High PE Growth Stocks
- California Resources Stock Could Be a Huge Long-Term Winner
- Financial Services Stocks Investing
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- How to Start Investing in Real Estate
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.